QCC374 0.015 mg ( DrugBank: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
86	肺動脈性肺高血圧症	3

86. 肺動脈性肺高血圧症

臨床試験数 : 1,205 / 薬物数 : 684 - (DrugBank : 124) / 標的遺伝子数 : 100 - 標的パスウェイ数 : 193

diseases per page:

Showing 1 to 3 of 3 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2016-001411-20-GB (EUCTR)	12/01/2018	09/01/2017	Long-term extension study of the safety and pharmacokinetics of QCC374 in PAH patients	Long-term, open label, multicenter, extension study to evaluate the safety and tolerability of QCC37 ...	Pulmonary arterial hypertension MedDRA version: 20.0;Level: PT;Classification code 10064911;Term: Pu ...	Product Code: QCC374 0.015 mg INN or Proposed INN: TBD Product Code: QCC374 0.06 mg INN or Proposed INN ...	Novartis Pharma AG	NULL	Not Recruiting			Female: yes Male: yes	38	Phase 2	United States;Taiwan;Germany;United Kingdom;Korea, Republic of
2	EUCTR2016-001411-20-DE (EUCTR)	17/10/2017	07/08/2017	Long-term extension study of the safety and pharmacokinetics of QCC374 in PAH patients	Long-term, open label, multicenter, extension study to evaluate the safety and tolerability of QCC37 ...	Pulmonary arterial hypertension MedDRA version: 20.0;Level: PT;Classification code 10064911;Term: Pu ...	Product Code: QCC374 0.015 mg INN or Proposed INN: TBD Product Code: QCC374 0.06 mg INN or Proposed INN ...	Novartis Pharma AG	NULL	Not Recruiting			Female: yes Male: yes	38	Human pharmacology (Phase 1): no Therapeutic exploratory (Phase 2): yes Therapeutic confirmatory - ( ...	United States;Taiwan;Germany;United Kingdom;Korea, Republic of
3	EUCTR2016-001412-38-DE (EUCTR)	27/07/2017	03/04/2017	Safety, pharmacokinetics and efficacy study of QCC374 in PAH patients	A randomized, parallel-group, placebo-controlled subject and investigator blinded study to assess th ...	Pulmonary arterial hypertension MedDRA version: 20.0;Level: PT;Classification code 10064911;Term: Pu ...	Product Code: QCC374 0.015 mg INN or Proposed INN: TBD Product Code: QCC374 0.06 mg INN or Proposed INN ...	Novartis Pharma AG	NULL	Not Recruiting			Female: yes Male: yes	38	Phase 2	United States;Taiwan;Germany;United Kingdom;Korea, Republic of

First Previous1Next Last